FEDERAL BUDGET 2018

8 May 2018
HEALTH BUDGET: A GOOD START BUT MORE TO DO ON DRUG SUPPORT SERVICES

The Australian Injecting and Illicit Drug Users League (AIVL) has welcomed some additional funding for drug treatment in
tonight’s Federal Budget but is disappointed that other key harm reduction measures have missed out. AIVL is calling
on the Australian Government to abandon its planned trial of drug testing for welfare recipients and redirect that
funding into frontline services in the wake of the Budget. AIVL is also calling for a stronger focus on people exiting
custodial settings to strengthen Australia’s efforts under the new national blood borne virus (BBV) and sexually
transmissible infections (STI) strategies.

The full media release may be found here.

REPORT CALLS FOR NSPs IN PRISONS

18 April 2018

REPORT CALLS FOR NEEDLE
&SYRINGE PROGRAMS IN PRISONS TO ADDRESS HEPATITIS C IN AUSTRALIA

The Australian Injecting and Illicit Drug Users League (AIVL) is today releasing a new report, looking at the needs of people living with Hepatitis C after leaving custodial settings in Australia. The report contains a series of recommendations aimed at addressing the spread of blood borne viruses (BBVs) in the Australian community more broadly, including trialling of a Needle and Syringe Program (NSP) in prison and increased focus on transitional arrangements for people returning to the community.

The full media release may be found here.

REPORT CALLS FOR BETTER ACCESS TO NSPs

9 April 2018

REPORT RECOMMENDS BETTER ACCESS TO NEEDLE AND SYRINGE PROGRAMS TO COMBAT BLOOD BORNE VIRUSES

The Australian Injecting and Illicit Drug Users League (AIVL) is today releasing a new report on Needle and Syringe
Programs (NSPs) in Australia, with a view to enhancing access for priority populations and reducing the impact of blood
borne viruses (BBVs) in Australia.
“The report looks at the pros and cons of different types of NSPs currently operating around the country and goes on to
make recommendations about ways to increase access and coverage. We already knew from previous studies that
investment in NSPs between 2000 and 2009 prevented nearly 97,000 Hepatitis C infections and 32,050 HIV infections –
for every dollar spent on NSPs, more than $4 will be returned in savings to the health systemi
. This new study looks at
ways to enhance the effectiveness of NSPs across the country to address access issues and maximise the public health
benefits,” said Melanie Walker, Chief Executive Officer (CEO) of AIVL.

The full report can be viewed here.